"You would not be in a hurry to go back home": patients' willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda.
Deborah Ekusai SebattaGodfrey SiuHenry W NabetaGodwin AnguzuStephen WalimbwaMohammed LamordeBadru BukenyaAndrew KambuguPublished in: BMC medical ethics (2020)
We found overwhelming willingness to participate in HIV treatment clinical trials. This was largely extrinsically influenced by the perceived material and health-related benefits. Investigators should pay attention to participants' concerns for benefits which may override the need to understand study procedures and risks.
Keyphrases
- hiv aids
- clinical trial
- antiretroviral therapy
- end stage renal disease
- human immunodeficiency virus
- ejection fraction
- hiv infected
- hiv positive
- healthcare
- depressive symptoms
- hepatitis c virus
- physical activity
- mental health
- prognostic factors
- randomized controlled trial
- phase ii
- health insurance
- study protocol
- hiv testing
- patient reported
- long term care
- replacement therapy